Global Pharmaceuticals & Biotech Large Cap High Growth Potential

Alnylam Pharmaceuticals

Market Cap: US$31.1b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

ALTEOGEN

Market Cap: ₩20.3t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Beijing Wantai Biological Pharmacy Enterprise

Market Cap: CN¥86.4b

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

Akeso

Market Cap: HK$78.7b

A biopharmaceutical company, researches, develops, manufactures, and commercializes antibody drugs.

Exelixis

Market Cap: US$10.0b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

argenx

Market Cap: €32.3b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Eli Lilly

Market Cap: US$677.4b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

BeiGene

Market Cap: US$26.1b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Vertex Pharmaceuticals

Market Cap: US$127.3b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

Torrent Pharmaceuticals

Market Cap: ₹1.1t

Engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.

Illumina

Market Cap: US$11.9b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Sandoz Group

Market Cap: CHF 14.4b

Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.

AstraZeneca

Market Cap: UK£159.4b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Innovent Biologics

Market Cap: HK$79.2b

A biopharmaceutical company, develops and commercializes monoclonal antibodies and other drug assets in the fields of oncology, ophthalmology, autoimmune, and cardiovascular and metabolic diseases in the People’s Republic of China.

Daiichi Sankyo Company

Market Cap: JP¥6.0t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

Sartorius Stedim Biotech

Market Cap: €16.5b

Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

Galderma Group

Market Cap: CHF 18.7b

Operates as a dermatology company worldwide.

AbbVie

Market Cap: US$316.8b

A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.

Divi's Laboratories

Market Cap: ₹1.5t

Engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.

Incyte

Market Cap: US$11.5b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Eurofins Scientific

Market Cap: €9.2b

Provides various analytical testing and laboratory services worldwide.

Bristol-Myers Squibb

Market Cap: US$104.5b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Celltrion

Market Cap: ₩34.4t

Develops and produces drugs based on proteins for the treatment of oncology in South Korea.

Teva Pharmaceutical Industries

Market Cap: US$15.6b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Lonza Group

Market Cap: CHF 38.2b

Supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.

Novo Nordisk

Market Cap: DKK 1.9t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Gilead Sciences

Market Cap: US$132.8b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Recordati Industria Chimica e Farmaceutica

Market Cap: €9.8b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

Natera

Market Cap: US$20.1b

A diagnostics company, provides molecular testing services worldwide.

GSK

Market Cap: UK£54.6b

Engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Roche Holding

Market Cap: CHF 204.7b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Astellas Pharma

Market Cap: JP¥2.4t

Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.

CSL

Market Cap: AU$118.2b

Researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

UCB

Market Cap: €26.4b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

Genmab

Market Cap: DKK 82.0b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

Bayer

Market Cap: €20.5b

Operates as a life science company worldwide.